Digital Therapeutics Clinical Trials: From Design to Data Interpretation

Medical Industry Feature

Kandungan disediakan oleh ReachMD. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh ReachMD atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

4d ago

MP3•Laman utama episod

Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Sarah Shizuko Morimoto, PsyD
Digital therapeutics are a rapidly developing type of treatment option across several therapeutic areas, including mental health. And while the technology is advancing rapidly, the science behind it needs time to catch up, so it’s important to evaluate the supporting evidence when considering digital therapeutics for mental health.¹ Joining Dr. Charles Turck to share her insights on how we can assess digital therapeutics is Dr. Sarah Shizuko Morimoto, Associate Professor of Population Health Sciences at the University of Utah in Salt Lake City.

Reference:

American Psychiatric Association. Accessed July 3, 2024. https://www.psychiatry.org/psychiatrists/practice/mental-health-apps/the-app-evaluation-model

Dr. Morimoto is a paid consultant of Otsuka.

November 2024 US.UNB.X.24.00100

33 episod

#Science #Health and Well-Being #Medicine #Pediatrics #Nutrition #ReachMD